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Abstract
We represent the results of the combined method of treatment and prevention of miscarriage in women with a multiple
pregnancy and a high risk of the threat of termination the pregnancy because of using the obstetric unloading pessaries,
combined with micronized progesterone. The efficiency of this method of treatment is evidenced by the rapid elimination
of clinical symptoms of threatened abortion, accelerating the regression of ultrasound markers, reducing the number of
complications in of pregnant women and reducing the time of their stay in hospital.
Goal: To evaluate the effectiveness of the handling the obstetric pessary in combination with micronized progesterone at
women with multifetal pregnancy and a high risk of miscarriage.
Materials and methods. We analyzed 120 cases of multifetal pregnancies with signs of miscarriage within the terms from
16 to 28 weeks. The first group of the examined women was: 40 pregnant women with twins and signs of miscarriage, who in
the scheme of treatment and prophylactic measures were offered to use the unloading obstetric pessaries in combination with
continuous therapy by natural micronized progesterone until 36 weeks of pregnancy. The second group included 40 pregnant
women with twins, who were laid seam on the cervix because of istmicocervical insufficiency and were applied short-term
courses of therapy by gestagens. The control group comprised 40 pregnant women with twins at the age of 16-28 weeks
of pregnancy who were conducted the therapy about the threat of miscarriage according to the current clinical protocols
(Order of the Ministry of Health of Ukraine No. 624). It was carried out the analysis of the course of pregnancy, childbirth, the
postpartum period and the state of neonatal adaptation in the surveyed groups.
Results. In the first group, urgent childbirth occurred in 34 (85%) cases, in group II in 29 (72.5%) cases, in control group –
in 25 (62.5%) cases. Cesarean delivery was performed in 7 (17.5%) patients of group I pregnant women, in 9 (22.5%) of
group II patients and in 11 (27.5%) in the pregnant group. When studying the state of neonatal adaptation of newborns in the
examined groups, the following results were obtained. The average weight of the newborns in group I was 3245 ± 280 g, in
group II 2865 ± 365 g, in the control group - 2975 ± 325 g (p>0.05). The evaluation of the state of newborns on the Apgar
scale, respectively at the 1st and 5th minutes, was respectively: in newborns of the I group, 7.5 ± 1.4 and 8.4 ± 1.3 points, in
group II - 7.3 ± 1.6 and 8.2 ± 1.1 points, in the control group – 7.2 ± 1.6 and 8.6 ± 1.2 (p1-p2> 0.05).
Conclusions. Comprehensive prophylaxis of non-pregnancy in multiple pregnancies, combining the use of a traumatic
cardiac cervix with the help of unloading obstetric pussies with progesterone preparations, allows prolonging pregnancy,
preventing the development of prematurity, contributes to the improvement of perinatal indicators.
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Problem statement and analysis of the
recent research
Non-pregnancy is the most common complication of gesta-
tional process in women with multiple pregnancies. Prema-
turity frequency is 54.3%, if compared with 12% at single-
pregnancy. Lost pregnancies make up almost 17% of all desir-
able, herewith 75-80% of miscarriages occurring on the early
stages, and, unfortunately, there is no tendency to decreasing
these indicators [1, 2, 3]. In this regard, the maximum pro-
longation of multiple pregnancies is an important condition
for reducing perinatal morbidity and mortality in this group
of high-risk patients [3, 5].
A whole chain of pathogenetic factors takes part in real-
izing miscarriage in multiple pregnancies. They include pla-
cental dysfunction, istmicocervical insufficiency, infectious-
inflammatory process, immune reactions and congenital or ac-
quired thrombophilia, extra genital diseases, neuroendocrine
disorders, most of which are accompanied by gestagens in-
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sufficiency starting at the stage of pre-gravida preparation
[5, 8, 9]. No effective way is proved to prevent premature
birth during multiple pregnancies. Overextension of the lower
segment of the uterus and excessive pressure on the cervix
often lead to the development of istmicocervical insufficiency
(ICI) [7, 9].
It’s demonstrated in a series of randomized trials that
progesterone is an effective means of preventing premature
birth in pregnant women in high risk group (premature birth
history or shortening of the cervix), the use of progesterone
in the prenatal period leads to a reduction in the preterm
pregnancy rate by 35%.
British experts conducted a research from the evaluation
the value of progesterone in preventing of premature births
with double (STOPPIT – Study of Progesterone for Prevent-
ing the Preterm Birth in Twins). It was concluded that the
use of progesterone in a double does not reduce the frequency
of premature birth or fetal death before 34 weeks of gesta-
tion [6]. Perhaps this is connected with insufficient dosage
of progesterone drugs. According to recent scientific data,
progesterone suppresses the expression of genes responsible
for the contractile activity of myometrium, is an antagonist of
prostaglandin F2α . It inhibits the activity of prostaglandins
by inhibition of their precursor – arachidonic acid. In recent
years, it’s disclosed the basic (first of all, immune) mecha-
nisms of the implementation of progesterone at prophylaxis
due to the fetus. The main mechanism that contributes to the
preservation of pregnancy is associated with the immunologi-
cal features of pregnancy – a progesterone-induced blocking
factor (PIBF). It is produced in the presence of a sufficient
amount of progesterone and prevents the rejection of a fetal
egg, which contains alien maternal antigens in the parent, and
is perceived as an allograft [9, 10].
It was noted that the tocolytic property is inherent to the
natural metabolites of progesterone (5b-pregnanonone, 5b-
pregnandiol and 5b-pregnondion), which is formed by the
interaction of progesterone with the 5b-reductase enzyme and
initiate a strong tocolytic effect, which is possible only with
the identity of natural progesterone, and therefore synthetic
analogues of progesterone do not have such properties [6, 7].
The drug of Lutein is a modern, innovative form of natu-
ral micronized progesterone for sublingual and vaginal use,
which is identical to endogenous. It creates maximum concen-
tration in plasma of blood and target organs, does not undergo
primary metabolism in the liver, which allows to achieve max-
imum concentration in the blood at low dosages and to choose
the most convenient way of input. Sublingual form is the
unique form of natural micronized progesterone in the world;
its advantages are rapid removal of clinical symptoms and
regression of ultrasound markers of the threat of abortion,
shorter period of staying in a hospital [7, 8]. The optimal
combination of different forms of micronized progesterone is
a combination of sublingual and vaginal form.
According to the recommendations of the European Soci-
ety of Obstetricians-Gynecologists in 2011, it’s recommended
the appointment of a vaginal form of progesterone in the
case of high risk of premature birth from the beginning of
the 2nd and during the third trimester of pregnancy. Society
for Maternal-Fetal Medicine in 2012 recommends the use of
vaginal progesterone since the installation of diagnosis of pre-
mature birth (even asymptomatic women for uterine cervical
length ≤20 mm) and before the 36th week of pregnancy. It
was found that at the background of using micronized proges-
terone, the risk of premature birth in the term to 34 weeks of
pregnancy is reduced by 42%, in addition, the incidence and
mortality rate of newborns, the development of respiratory
distress syndrome (RDS) are significantly reduced to 52-61%,
and the need for artificial ventilation of the lungs is reduced
too (R. Romero et al., 2012) [8].
However, despite the proven high effectiveness of pro-
gesterone therapy of danger of premature birth, the issue of
prescribing micronized progesterone drugs, the most optimal
form of drug administration and the duration of treatment
remains discursive.
The objective of the research: to sum up the effective-
ness of the using the unloading obstetric pessaries in combina-
tion with micronized progesterone in women with multifetal
pregnancy and high risk of non-compliance.
1. Materials and methods
The research was conducted on the basis of the Sumy Regional
Clinical Perinatal Center during 2012-2016. We analyzed
120 cases of multiple pregnancies with signs of miscarriage
in terms of 16 - 28 weeks. The first group of the exam-
ined patients consisted of 40 double-pregnant women with
signs of non-pregnancy, which in the scheme of treatment-
prophylactic measures were suggested the use of unloading
obstetric pessary in combination with continuous therapy by
natural micronized progesterone for the period of 36 weeks of
gestation. The second group consisted of 40 pregnant women
with twins, who had a septum on the cervix in connection
with istmicocervical insufficiency, and short-term courses of
progesterone therapy. The control group consisted of 40 twin
pregnancies in the period of 16 - 28 weeks of gestation which
were being treated for the risk of miscarriage in accordance
with the current clinical protocols. In addition to clinical ex-
amination methods and generally accepted laboratory studies,
transvaginal cervicometry was performed to assess the threat
of pregnancy interruption (PI), as well as an assessment of the
state of the cervix according to Stemberg, where the score of
5 and higher was indicative for the prevention and treatment
of the threat of abortion.
Transvaginal cervicometry was performed with the help of
the modern ultrasound apparatus “MEDISON” using transvagi-
nal sensor of 6.5 MHz At later dates of convective sensors
3.5 and 5 MHz in two-dimensional echo modes in accordance
with terms of 10 - 13 weeks, it determined the viability, num-
ber of fetus, and the number of choriones, the thickness of
the collar space, the birth defects, and the exact term of ges-
tation. In the later period within 18-22 and 28 - 34 weeks of
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pregnancy, – ultrasound photometry was performed; placenta
researches included measurement of its thickness and evalua-
tion of the degree of maturity by P.Grannum et al. (1979).
The main criteria for the threat of abortion were a shorten-
ing of the cervix to 2.0 cm or more, the opening of the cervical
canal at 0.9 cm and above, and the ratio of the length of the
cervix to its diameter at the level of internal cavity – 1.16 cm.
Pessary was carried up to a pregnant woman within 18 - 28
weeks in the outpatient conditions and in a hospital. Regular
bacteriological examination of vaginal smears, transvaginal
cervicometry and the control of the location of pessary every
3 to 4 weeks were performed on women after the introduction
of pessary. The mechanism of action of the pessary is to
reduce the burden of the intrauterine pressure of the fetal
egg, the closure of the cervix through the walls of the central
opening of the pessary, the formation of a shortened and
partly open cervix and the reduction of pressure on it due to
physiological sacralization of the cervix and a partial transfer
of intrauterine pressure to the anterior wall of the uterus, the
preservation of the mucous membrane. Indications for the
introduction of obstetric discharge pessaries were: the risk
of non-pregnancy associated with progressive changes in the
cervix in patients with multiple pregnancy, including those
after using ART, as well as patients with multiple pregnancies,
which had a history miscarriage at a later date, premature birth,
and the usual miscarriage of pregnancy. Contraindications
to the introducing the obstetric pessary were also taken into
account: recurrent bleeding from the genital tract in the 2nd-
3rd trimester of pregnancy, expressed by the ICI with prolapse
of the productive bladder and violation of its integrity. In
inflammatory diseases of the vagina, cervix, external genitalia,
a preliminary sanitation of the infection was carried out with
subsequent bacteriological control.
In the planned order, obstetric pessary was withdrawn in
37 weeks of pregnancy or with the onset of labor. Before the
introduction of the pessary, the sanitation of the genital tract
was carried out with an antiseptic agent, taking into account
the peculiarities of the micro biocenosis of the vagina. Along
with the introduction of unloading obstetric pessaries women
of group 1 were assigned natural micronized progesterone of
Lutein in the form of sublingual and vaginal form. Dosage for-
mulation and method of use: in women of the 1st group with
premature birth - micronized progesterone 200 mg vaginal
from 16 - 20 to 34 - 37 weeks; with a short cervix (length in
the second trimester shorter than 15 mm) – lutein, micronized
progesterone vaginal 200 mg from 16 - 20 to 34 - 37 weeks
of gestation. Sublingual tablets were given l for 100 mg (2
tablets) 3 times a day, at the risk of miscarriage, premature
birth, as a pregradar preparation. In addition, a pregnant with
twins after IVF during 77 days after the transferring the em-
bryos was prescribed a sublingual form of Lutein for 100
mg 3-4 times a day. The presence of sublingual and vaginal
forms of micronized progesterone allows to go from one form
to another if needed and simultaneously combine the use of
both forms for the rapid saturation of the body with pregnant
progesterone in conditions of progesterone deficiency to elim-
inate the symptoms of the threat of abortion. At the time of
being in a hospital, in the presence of signs of the threat of
abortion, a tocolytic therapy with nifedipine was prescribed
for 48 hours.
Pregnant of group 2 was assigned tocolytic therapy with
nifedipine for 48 hours during the period of surgical cardiac
surgery, during the staying in a hospital, synthetic proges-
terone (dydrogesterone) preparation was included in short-
term courses under the control of the level of progesterone
in the blood of the pregnant woman. The evaluation of the
effectiveness of the proposed prophylactic treatment scheme
was based on clinical and laboratory monitoring of pregnancy
and fetus, as well as a comparative analysis of pregnancy
outcomes in the women surveyed.
Statistical processing of the material was carried out using
the methods of variation and paired statistics, and also using
the method of difference using Student’s t-criterion [4]. The
obtained results were considered reliable if the coefficient of
reliability p, which was found on the Student’s table, was less
than 0.05.
2. Results of the research and their
discussion
The average age of pregnant women probably did not differ.
Thus, in the examined group I, it was 28.5 ± 1.5 years, in
the group II – 29.0 ± 1.4, in the control group – 27.5 ± 1.6
(p>0.05). By parity, half of the women in group I were pre-
pregnant, the rest of the women had repeated pregnancies,
all pregnant women had obsessive obstetric history (medical
abortions, involuntary miscarriage, dead pregnancy), of which
11 women had a previous pregnancy with normal childbirth, 9
had in history spontaneous abandonment and abortion. In 17
(42.5%) patients of the group II, this pregnancy was the first,
the remaining 23 women had repeated pregnancies, 18 (45%)
patients had involuntary miscarriages and abortions in history.
Extragenital pathology was not surveyed.
The main criteria for the threat of abortion were a shorten-
ing of the cervix to 2.0 cm or more, the opening of the cervical
canal at 0.9 cm and above, and the ratio of the length of the
cervix to its diameter at the level of internal cavity – 1.16 cm.
During the transvaginal cervicometry, it was found that the
pace of cervical shortening in multiple pregnancy significantly
exceeded those with unipolar. Under the threat of premature
birth, the length of the cervix was 19 ± 2.3 mm, with changes
in the cervix not only being shortened, but also by the V- or U-
like opening of the internal lobe and cervical canal. In patients
with double cervical length <19 mm is a risk criterion for
“early” preterm labor. These pregnant women were given the
prophylactic therapy of the threat of preterm labor.
By 22-24 weeks, multifetal pregnancies indicated lower
cervical length indices than those with single pregnancy: 27.5
± 4.5 mm in patients of group II against 32.2 ± 4.9 mm
in group I and 28.7 ± 3.7 mm – in the control group. The
dynamics of cervical shortening was significantly slower in
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Table 1. Length of cervix in ultrasound examination
Term of
pregnancy,
weeks
Control
group, mm
Group II,
length of the
cervix, mm
Group I,
length of the
cervix, mm
Less than 15 35.4±5.6 32.2±5.43 35.2±4.3
16-18 34.3±4.3 31.02±5.12 34.0±3.9
19-21 31.3±3.8 30.9±5.5 33.3±4.2
22-24 28.7±3.7 27.5±4.5 32.2±4.9
25-27 26.7±3.6 27.2±3.5 31.2±4.5
28-30 25.1±2.5 26.15±3.9 29.2±4.1
31-33 23.8±3.2 25.3±4.2 27.2±4.0
34-36 21.4±3.1 21.6±4.4 23.8±3.1
group I patients, who had been assigned an unloading obstetric
pessary and assigned a natural micronized progesterone.
In the introduction of obstetric pessary there was no com-
plication in any of the pregnant women in the first group,
even with prolonged use of pessary for 20 weeks, no cases of
trophic complications of the vagina were noted. In 6 (12.5%)
pregnant women it was necessary to treat vaginal candidiasis
to remove pessary. Tocolytic therapy according to the Order
of the Ministry of Health # 624 was performed in 13 (32.5%)
women in the presence of complaints of pain in the abdomen,
both before and after the introduction of pessary. The analysis
of clinical results of the application of the complex method
of treatment and prevention of non-pregnancy in pregnant
women with multiple pregnancies using unloading obstetric
pessary in combination with natural micronized progesterone
is represented in Table 2.
Thus, the reduction of clinical symptoms of AR (abortion
risk) in group I was already observed at 1.5 ± 1.0 days, in the
control group – 2.0 ± 1.2, in the group II – 3.0 ± 2.0 days,
regression of ultrasound markers of AR (normalization of the
thickness of the myometrium, narrowing of the lumen of the
cervical canal and slowing down the dynamics of the cervix
shortening) were noted for 3.2 ± 0.5 days in group I, in the
control group – by 3.5 ± 1.2 days, and by 4.0 ± 1.0 days in
pregnant women in group II.
In the group I, overweight occurred in 34 (85%) cases, in
the group II – in 29 (72.5%) cases, and in the control group –
25 (62.5%) cases. The course of childbirth was complicated
by premature rupture of the membranes (PRM) in 7 (17.5%)
patients in Group I, 10 (25.0%) women in the group II and 13
(32.5%) in the control group, the anhydrous interval did not
exceed 8.4 ± 1.5 hours and 12.4 ± 2.3 hours accordingly (p
<0.05). The average duration of childbirth was 10.4 ± 2.3 in
the group I, 8.6± 1.5 hours in the second group and 9.5± 2.6
hours in the control group. Blood loss in childbirth through
natural delivery lines was on average in women of the group I
- 290 ± 25 ml, 315 ± 27 ml in the second group and 320 ±
37 ml in the control group. There was no pathological blood
loss during childbirth due to natural birth lines in the groups
under investigation.
Childbirth by Caesarean section was performed in 7 (17.5%)
pregnant of the group I, in 9 (22.5%) patients of the II group
and in 11 (27.5%) pregnant of the control groups. In the
control group, premature birth occurred in 15 (37.5%) preg-
nant women, perinatal losses were 2.5% (one newborn). In
pregnant women of the 2nd group, which was the subject
of surgical treatment of the ICI, chorioamnionitis developed
in one case; therefore, antibiotic therapy and circular suture
were prescribed, this pregnancy occurred within a period of
28 weeks, there was a perinatal loss of one newborn, which
was 2.5%.
The duration of stay in the hospital was 12 ± 1.2 days in
women of group I; 21 ± 1.6 days in the group II and 18 ± 1.3
in the control group (p<0.05).
The following results were obtained in studying the state
of neonatal adaptation of newborns. The average weight of
newborns of the group I was 3245 ± 280 g, in the group II
2865 ± 365 g, in the control group 2975 ± 325 g (p>0.05).
Evaluation of the state of newborns by using the Apgar scale
at the 1-st and 5-th minutes was, accordingly, in the newborns
of the group I: 7.5 ± 1.4 and 8.4 ± 1.3 points, in the second
group – 7.3 ± 1.6 and 8.2 ± 1.1 points, in the control group –
7.2 ± 1.6 and 8.6 ± 1.2 (p1-p2>0.05).
3. Conclusions
Thus, according to the results of the study, the following
conclusions can be drawn:
1. The use of unloading obstetric pessary is an effective
method of prevention and treatment of pregnancy loss in
pregnant women with multifetal pregnancies, reducing
the frequency of late abortion and preterm childbirth,
perinatal loss due to total exposure, leading to closure
and sacralization of the cervix, redistribution of the pres-
sure of the fetal egg, better formation of the truncated
and partially exposed cervix.
2. The method of usage unloading obstetric pessary is
pathogenically reasonable in pregnant women with mul-
tiple pregnancies and allows prolonging pregnancy to
terminate in 85% of women in the study group, reducing
the medication burden on pregnant women and fetus.
3. The combined use of noninvasive cardiology and mi-
cronized progesterone reduces the risk of premature
birth more than twice. The use of natural micronized
progesterone promotes the rapid elimination of clinical
symptoms and regression of ultrasound markers of the
threat of abortion, shortens the term of being in hos-
pital, and promotes 50% reduction in the number of
complications compared with other gestagens.
4. In the application of non-invasive cerclage, it is more ap-
propriate to prescribe the sublingual form of micronized
progesterone, since the use of pessaries may violate the
absorption of the vaginal form of progesterone.
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Table 2
Survey group Number of
women
Reducing clinical
symptoms of AR,
day
Regression
US-markers of
AR, day
PRM, number of
cases,%
Duration of stay
in hospital, days
Control group 40 2.0±1.2* 3.5±1.2* 13 (32.5%)* 18±1.3*
Group II 40 3.0±2.0** 4.0±1.0** 10 (25.0%)** 21±1.6**
Group I 40 1.5±1.0 3.2±0.5 7 (17.5 %) 12±1.2
Note: *- the index of reliability between groups.
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